FIELD: medicine; ophthalmology.
SUBSTANCE: invention is characterised by compositions and methods of application of such compositions applicable for injection in posterior ocular segment of people and animals. These compositions include particles containing corticosteroid component of water-soluble factor less than 10 mg/ml at 25°C presented in therapeutically effective amount, thickener and aqueous carrier. Viscosity of compositions is at least about 10 centipoises or about 100 centipoises at shear rate 0.1 c-1. Preferable version of invention implies that viscosity is within the range 140000 centipoises to 300000 centipoises. Particles in compositions mainly remain suspended during continuous period of time.
EFFECT: invention provides stability of composition d during continuous period of time without resuspending.
57 cl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
GEL POLYSACCHARIDE COMPOSITIONS AND METHODS FOR PROLONGED DRUG DELIVERY | 2008 |
|
RU2472487C2 |
LOW-VISCOUS HIGHLY FLOCCULATED TRIAMCINOLONE ACETONIDE SUSPENSIONS FOR INTRAVITREAL INJECTIONS | 2009 |
|
RU2481842C2 |
PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS FOR THEIR PRODUCTION AND USE | 2013 |
|
RU2789479C2 |
PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF | 2013 |
|
RU2663117C2 |
LIPOSOME FORMULATIONS | 2013 |
|
RU2680096C2 |
COMPOUNDS FOR TREATING/PREVENTING INFLAMMATORY OPHTHALMIC DISEASES | 2011 |
|
RU2582609C2 |
METHOD FOR TREATING ATROPHIC AGE RELATED MACULAR DEGENERATION | 2009 |
|
RU2668371C2 |
METHOD OF TREATING ATROPHIC AGE-RELATED MACULAR DEGENERATION | 2009 |
|
RU2521338C9 |
DRUG-INDUCED LIPOATROPHY FOR COSMETIC PURPOSES | 2010 |
|
RU2530629C2 |
METHOD OF TREATING ELEVATED INTRAOCULAR PRESSURE USING INTRAOCULAR SUSTAINED RELEASE DRUG DELIVERY SYSTEM | 2014 |
|
RU2664686C2 |
Authors
Dates
2008-10-20—Published
2004-11-08—Filed